[Application of Navosure impedance controlled endometrial ablation system in treating the intrauterine disease].
To explore the feasibility, safety and effectiveness of treatment by Novasure system in abnormal uterine bleeding caused by endometrial polyps (AUB-P) or uterine leiomyomas up to 3 cm (AUB-LSM). From June 2011 to June 2012, 30 women with abnormal uterine bleeding caused by AUB-P and AUB-LSM were treated by NoveSure system. The clinical efficacies and complications were followed up at months 1, 3, 6, 12. All operations were completed successfully. The mean operative duration was (84 ± 6) (60-120) s. The volume of blood loss was <10 ml. And the follow-up period was 1, 3, 6 and 12 months. The effective rate was 100% (30/30), 96.67% (29/30), 93.33% (28/30) and 96.67% (29/30) respectively. The rate of amenorrhea was 76.67% (23/30), 70% (21/30), 70% (21/30) and 76.67% (23/30) respectively. The degrees of satisfaction were 100% (30/30), 96.67% (29/30), 96.67% (29/30) and 96.67% (29/30).No severe perioperative or postoperative complications occurred. Navosure system is both safe and efficacious for abnormal uterine bleeding caused by AUB-P and AUB-LSM. And it is worth wider popularization.